Get started
Author

Pratap Neelakantan

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies
2013 · Pratap Neelakantan, Gareth Gerrard, et al. · Blood · 95
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma
2024 · David Austin, Rebecca H. Maier, et al. · JACC CardioOncology · 48
PDF
Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy
2012 · P. Neelakantan, D. Marin, et al. · Haematologica · 38
PDF
Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study
2020 · Dragana Milojkovic, Nicholas C. P. Cross, et al. · British Journal of Haematology · 34
PDF
The management of myelofibrosis: A British Society for Haematology Guideline
2023 · Donal P. McLornan, Bethan Psaila, et al. · British Journal of Haematology · 30
PDF
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy
2020 · Stephen Booth, John Willan, et al. · European Journal Of Haematology · 26
PDF
Combined IL‐6 and JAK/STAT inhibition therapy in COVID‐19‐related sHLH, potential game changer
2020 · Sophie Portsmore, Thien Ngoc Tran Nguyen, et al. · British Journal of Haematology · 23
PDF
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline
2023 · Donal P. McLornan, Anna L. Godfrey, et al. · British Journal of Haematology · 10
PDF
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm
2021 · Richard A. Salisbury, Natalia Curto-Garcia, et al. · Leukemia · 9
PDF
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study
2022 · Adam J. Mead, Nauman M. Butt, et al. · Therapeutic Advances in Hematology · 8
Excellent outcome after repeated changes of tyrosine kinase inhibitor therapy for chronic myeloid leukaemia in complete cytogenetic response due to minor side effects
2013 · Pratap Neelakantan, Katayoun Rezvani, et al. · British Journal of Haematology · 6
Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR–ABL1
2019 · Danmei Xu, Simone Claudiani, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 5
Breast cancer metastasizing to the tongue.
2008 · Pratap Neelakantan, Sean R McLean, et al. · PubMed · 4
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience
2019 · Faouzi Djebbari, Huben Hubenov, et al. · British Journal of Haematology · 2
The Transformative Journey of Chronic Myeloid Leukemia
2018 · Pratap Neelakantan, Adam Mead · International Journal of Hematologic Oncology · 2
PDF
Can the Combination of the Measurement of BCR-ABL1 Transcript Levels At 3 and 6 Months Improve the Prognostic Value of the 3 Month Measurement?
2012 · Pratap Neelakantan, Gareth Gerrard, et al. · Blood · 2
Prospective Cohort Study of Non-COVID Infection in Patients with AML/MDS Undergoing Treatment: Implications for Practice
2024 · Justin CT Loke, Charlotte Gaskell, et al. · Blood · 1
PDF
A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study)
2019 · Adam J. Mead, Tim Somervaille, et al. · Blood · 1
Nilotinib for treatment of chronic myeloid leukemia in light of the current evidence and guidelines
2013 · Pratap Neelakantan, Jane F Apperley · Clinical Practice · 1
Is Major Molecular Response a Safe Haven Against Blast Crisis in Cml Patients Treated with Imatinib?
2012 · Pratap Neelakantan, Dragana Milojkovic, et al. · Blood · 1
Real-world effectiveness and safety of elranatamab in patients with relapsed/refractory multiple myeloma: Preliminary results from the prospective, non-interventional MagnetisMM-16 study.
2026 · Jindriska Lindsay, Werner Freier, et al. · Journal of Clinical Oncology
PDF
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic
2026 · Lorna Hazell, Clio Pillay, et al. · BMJ Open
Pb1886: Real World Experience of Venetoclax-azacytidine Combination in Frail Elderly Patients Unfit for Intensive Chemotherapy
2023 · Muhammad Naim Bin Che Rahimi, Pratap Neelakantan · HemaSphere
Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program
2021 · (Justin) Ching Ting Loke, Charlotte Gaskell, et al. · Blood
PDF
Real-world data from the United Kingdom on the sequencing of second generation tyrosine kinase inhibitors for the treatment of chronic phase Philadelphia chromosome-positive chronic myeloid leukaemia
2020 · Jenny Byrne, Andrew Mead, et al. · British Journal of Haematology
Works count: 37
Citation count: 346
H-index: 9
I10-index: 8
Year
Topic
Type